This inventor holds 4 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Schering Corporation, Dendreon Corporation. Active years: 2006-2012.
Location History:
- Rockaway, NJ (US) (2007)
- Kenilworth, NJ (US) (2011)
- Edison, NJ (US) (2006 - 2012)
Company Filing History:
4 out of 1,829 
3 out of 53 
Years Active: 2006-2012
Title: Siska Hendrata: Innovator in Hepatitis C Research
Introduction
Siska Hendrata is a notable inventor based in Kenilworth, NJ (US). She has made significant contributions to the field of medical research, particularly in the development of treatments for hepatitis C virus (HCV). With a total of 4 patents, her work has the potential to impact the lives of many affected by this virus.
Latest Patents
Hendrata's latest patents include innovative compounds that serve as NS3-serine protease inhibitors of the hepatitis C virus. The first patent discloses novel compounds with HCV protease inhibitory activity, along with methods for preparing these compounds. Additionally, it outlines pharmaceutical compositions that incorporate these compounds and methods for using them to treat disorders associated with the HCV protease. Another patent focuses on sulfur compounds that also act as inhibitors of the hepatitis C virus NS3 serine protease, further emphasizing her commitment to advancing treatment options for this disease.
Career Highlights
Throughout her career, Siska Hendrata has worked with prominent organizations such as Schering Corporation and Dendreon Corporation. Her experience in these companies has allowed her to develop her expertise in pharmaceutical research and innovation.
Collaborations
Hendrata has collaborated with esteemed colleagues, including Anil K Saksena and Viyyoor Moopil Girijavallabhan. These partnerships have contributed to her success in the field and have fostered a collaborative environment for research and development.
Conclusion
Siska Hendrata's contributions to hepatitis C research through her patents and collaborations highlight her role as an influential inventor in the medical field. Her work continues to pave the way for advancements in treatment options for those affected by hepatitis C virus.